Ascher N L, Simmons R L, Marker S, Najarian J S
Arch Surg. 1978 Jan;113(1):90-4. doi: 10.1001/archsurg.1978.01370130092018.
We report five cases of Listeria monocytogenes infection in renal transplant patients at the University of Minnesota and compare them to 15 additional patients reported on in the United States literature. All patients were noted to have fever, malaise, and nonspecific symptoms of infection. There were no consistent diagnostic laboratory findings except for positive bacteriologic studies. Successful treatment consisted of intravenous penicillin G potassium in most cases (ampicillin sodium was required in two patients). Mortality was low, with only one patient of the 20 (and no Minnesota patients) dying of listeriosis. The time interval from transplant to infection was definitively longer in the Minnesota patients; this may be due to the routine use of sulfisoxazole following renal transplantation. Listeria infection, though mild itself, may herald other infectious processes in the immunoincompetent host.
我们报告了明尼苏达大学肾移植患者中5例单核细胞增生李斯特菌感染病例,并将其与美国文献中另外报告的15例患者进行了比较。所有患者均有发热、不适及非特异性感染症状。除细菌学研究呈阳性外,无一致的诊断性实验室检查结果。多数病例成功的治疗方法是静脉注射青霉素G钾(2例患者需要使用氨苄西林钠)。死亡率较低,20例患者中仅有1例(明尼苏达患者中无死亡病例)死于李斯特菌病。明尼苏达患者从移植到感染的时间间隔肯定更长;这可能是由于肾移植后常规使用了磺胺异恶唑。李斯特菌感染本身虽轻,但可能预示免疫功能不全宿主中会出现其他感染过程。